71195-76-1

Basic information

• Product Name: hydroxy-(4-methoxy-phenyl)-methanesulfonic acid ; anisaldehyde sulfite sodium
• Synonyms: hydroxy-(4-methoxy-phenyl)-methanesulfonic acid ; anisaldehyde sulfite sodium
• CAS NO: 71195-76-1
• Molecular Weight: 240.212
• Mol File: 71195-76-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: hydroxy-(4-methoxy-phenyl)-methanesulfonic acid ; anisaldehyde sulfite sodium(CAS DataBase Reference)
• NIST Chemistry Reference: hydroxy-(4-methoxy-phenyl)-methanesulfonic acid ; anisaldehyde sulfite sodium(71195-76-1)
• EPA Substance Registry System: hydroxy-(4-methoxy-phenyl)-methanesulfonic acid ; anisaldehyde sulfite sodium(71195-76-1)

Safety Data

• Hazardous Substances Data: 71195-76-1(Hazardous Substances Data)

Upstream product

• 123-11-5 4-methoxy-benzaldehyde 

Downstream Products

• 109182-54-9 ethyl 2-(4-methoxyphenyl)-4-<(diphenylmethyl)amino>-1H-imidazo<4,5-c>pyridin-6-ylcarbamate 
• 109182-58-3 ethyl 4-amino-2-(4-methoxyphenyl)-1H-imidazo<4,5-c>pyridin-6-ylcarbamate 
• 30458-48-1 5-methoxy-2-(4-methoxyphenyl)-1H-benzimidazole 
• 96954-35-7 2-(4-methoxyphenyl)-5-nitro-1H-benzo(d)imidazole 

Relevant articles and documents

Studies on analgesic and anti-inflammatory activities of 1- dialkylaminomethyl-2-(p-substituted phenyl)-5-substituted benzimidazole derivatives

In this study the analgesic and anti-inflammatory activity of 1,2,5- trisubstituted benzimidazole derivatives have been examined. Analgesic activities of these compounds were investigated by using the modified Koster test. Among the compounds synthesized especially compound 1g (1- diethylaminomethyl)-2-(p-chlorophenyl)-5-nitro benzimidazole hydrochloride) has shown higher activity than acetylsalicylic acid (ASA) and indometacin. Compound 1e (1-(diethylaminomethyl)-2-(p-methoxyphenyl)-5-nitro benzimidazole hydrochloride, 1f (1-(diethylaminomethyl)-2-(p-tolyl)-5-nitro henzimidazole hydrochloride and 1i (1-(pipenridinomethyl)-2-(p-methoxyphenyl)-5-nitro benzimidazole hydrochloride) proved as potent as the standard ASA. Therefore the compounds 1e, 1f, 1g and 1i were screened for their anti-inflammatory activities using the carrageenan-induced hind paw edema test. Except 1g all compounds were almost inactive against this model of inflammation compared to indometacin.